Acute Myeloid Leukemia with an FMS-like Tyrosine Kinase 3-tyrosine Kinase Domain Mutation Developing Gilteritinib-induced Differentiation Syndrome. [PDF]
Kubara C +7 more
europepmc +1 more source
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predisposition. [PDF]
Swaroop A +9 more
europepmc +1 more source
Relapse following FLT3 inhibitor cessation in FLT3-ITD-positive AML: lessons from two clinical cases. [PDF]
Georgi JA +6 more
europepmc +1 more source
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation. [PDF]
Arora S +23 more
europepmc +1 more source
TIP-20, a novel feline McDonough sarcoma-like tyrosine kinase 3 inhibitor with potent antileukemia activity. [PDF]
Pang H +8 more
europepmc +1 more source
XII. KÜTÜPHANE HAFTASI MÜNASEBETİYLE TKD GENEL BAŞKANLIĞINA GÖNDERİLEN TELGRAFLAR
openaire +2 more sources
An emerging triplet option for newly diagnosed <i>FLT3</i>-mutated acute myeloid leukemia. [PDF]
Boussi L, Goldberg AD.
europepmc +1 more source

